Condition 1: Per-cutaneous coronary angioplasty. Condition 2: Coronary artery bypass surgery. Condition 3: Heart valve surgery. Condition 4: Cardiac transplantation. Presence of coronary angioplasty implant and graft Presence of aortocoronary bypass graft Presence of other heart-valve replacement Presence of other heart-valve replacement
Conditions
Interventions
Intervention 1: Intervention group: Participants In this group receives the booklet. We ask them filling tables for 2 months. Intervention 2: Intervention group: .The patients will received the home b
Sponsors
Mashhad University of Medical Sciences
Razavi hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The patient or immediately family has smart phones. Patients under coronary angioplasty Patients undergo coronary artery bypass surgery Patients undergo heart valve surgery Patients undergo cardiac transplantation Patients who have completed informed consent and are willing to enter the study.
Exclusion criteria
Exclusion criteria: Primary phase after acute coronary syndrome (up to two days) Untreated arrhythmia Acute heart failure Uncontrolled hypertension (systolic upper than 200 or diastolic over 100) Advanced coronary artery blockage Acute Myocarditis and pericarditis Congenital heart failure and cardiomyopathy Acute systemic diseases (creatinine more than 3 and liver enzymes more than 3 times) Uncontrolled Diabetes There is a clot in the heart VTE AF with uncontrolled response Patients who are not able to study information or are unable to complete questionnaires Patients who cannot attend the study for any reason (such as psychiatric disorder, dementia, life-threatening concomitant illness, motor disability). Patients who have received cardiac rehab in the last 12 months. Patients who have received intracardiac defibrillator (ICD) or Cardiac Resynchronization Therapy (CRT) or a combination of both within the last 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 6 minute walk test. Timepoint: Baseline, 2 and 6 months after baseline. Method of measurement: By nurse in cardiac rehabilitation center.;Health related quality of life. Timepoint: Baseline, 2 weeks and 2 and 6 months after baseline. Method of measurement: SF-36 questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Psychological well-being. Timepoint: Baseline, 2 weeks , 2 and 6 months after baseline. Method of measurement: Hospital Anxiety Depression Scale.;Blood tests. Timepoint: Baseline, 2 and 6 months after baseline. Method of measurement: in the lab.;Adherence to cardiac rehabilitation programs. Timepoint: Two weeks, 2 months and 6 months after baseline. Method of measurement: Participate in the training sessions or self reported data in application.;Re-hospitalization due to heart disease. Timepoint: Two months and 6 months after baseline. Method of measurement: Self reported and check the patient's medical record.;Mortality due to heart disease. Timepoint: Six months after baseline. Method of measurement: Check the patient's medical record. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSamaneh Bakhshayesh
Mashhad University of Medical Sciences
Outcome results
None listed